EUVIMEDEUVIMED entdecken
Open Access

Myasthenia thymus reprograms class-switched B cells into BAFF-dependent survivors

Yuanqing Yan iD, Diego Avella Patino, Yimeng Zhao iD, Xin Wu iD, G R Scott Budinger iD, Ankit Bharat iD

Science Advances · 14.08.2026 · 12 (33)

DOI: 10.1126/sciadv.aec3842 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 14.08.2026. Verfasst von Yuanqing Yan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Division of Thoracic Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA. Hauptthemen laut MEDLINE: B-Cell Activating Factor, Myasthenia Gravis, B-Lymphocytes, Thymus Gland. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIA NIH HHS, NHLBI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myasthenia gravis (MG) presents a clinical challenge where autoantibody titers poorly predict disease severity, and thymectomy provides inconsistent benefits. We hypothesized that thymic B cells acquire survival mechanisms that bypass canonical tolerance checkpoints, enabling persistence independent of antigen-specific selection. Using single-cell RNA sequencing, V(D)J repertoire analysis, and spatial transcriptomics to generate the largest MG atlas to date (237,661 cells), we identified a tolerance checkpoint swap in MG pathogenesis. Pathological class-switched B cells within thymic germinal centers exhibited reduced antigen presentation ( CD74 and CD1C ) and diminished CD40 costimulation while up-regulating TNFRSF17 to engage BAFF-driven survival. This shift allows polyclonal autoreactive B cells to evade stringent selection and seed peripheral sites. T follicular helper cells supported this reprogramming via increased TNFSF13B and CHGB expression, with the latter facilitating dopamine-mediated synaptic acceleration. These findings offer insight into clinical paradoxes in MG and point to the BAFF-BCMA axis as a potential therapeutic target and biomarkers for disease activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B-Cell Activating FactorMyasthenia GravisB-LymphocytesThymus GlandImmunoglobulin Class SwitchingHumansAnimalsGerminal Center

Substanzen

B-Cell Activating FactorTNFSF13B protein, human

Autor:innen und Institutionen

  • Department of Surgery, Division of Thoracic Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
  • DeWitt Daughtry Family Department of Surgery, Miller School of Medicine, University of Miami, Coral Gables, FL 33124, USA.
  • Department of Medicine, Division of Pulmonary and Critical Care Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.

ORCID-Profile: Yuanqing Yan, Yimeng Zhao, Xin Wu, G R Scott Budinger, Ankit Bharat

Förderung

  • NHLBI NIH HHS
  • NIA NIH HHS
  • NHLBI
  • NIA

Zitieren

APA

Yan, Y., Patino, D. A., Zhao, Y., Wu, X., Budinger, G. R. S., & Bharat, A. (2026). Myasthenia thymus reprograms class-switched B cells into BAFF-dependent survivors. Science Advances, 12(33). https://doi.org/10.1126/sciadv.aec3842

Vancouver

Yan Y, Patino DA, Zhao Y, Wu X, Budinger GRS, Bharat A. Myasthenia thymus reprograms class-switched B cells into BAFF-dependent survivors. Science Advances. 2026;12(33). doi:10.1126/sciadv.aec3842

BibTeX
@article{Yan2026,
  author = {Yan, Yuanqing and Patino, Diego Avella and Zhao, Yimeng and Wu, Xin and Budinger, G R Scott and Bharat, Ankit},
  title = {Myasthenia thymus reprograms class-switched B cells into BAFF-dependent survivors},
  journal = {Science Advances},
  year = {2026},
  volume = {12},
  number = {33},
  doi = {10.1126/sciadv.aec3842}
}
Kostenlos starten →